These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12778817)

  • 1. [The structure and function of RAGE].
    Zhao SC; Hou FF; Jiang Y
    Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):71-3. PubMed ID: 12778817
    [No Abstract]   [Full Text] [Related]  

  • 2. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
    Ramasamy R; Yan SF; Schmidt AM
    J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability.
    Kumano-Kuramochi M; Ohnishi-Kameyama M; Xie Q; Niimi S; Kubota F; Komba S; Machida S
    Biochem Biophys Res Commun; 2009 Aug; 386(1):130-4. PubMed ID: 19501570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction.
    Matsumoto S; Yoshida T; Murata H; Harada S; Fujita N; Nakamura S; Yamamoto Y; Watanabe T; Yonekura H; Yamamoto H; Ohkubo T; Kobayashi Y
    Biochemistry; 2008 Nov; 47(47):12299-311. PubMed ID: 19032093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressed RAGE.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Aug; 2004(31):nf71. PubMed ID: 15295105
    [No Abstract]   [Full Text] [Related]  

  • 6. Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction.
    Simm A; Casselmann C; Schubert A; Hofmann S; Reimann A; Silber RE
    Exp Gerontol; 2004 Mar; 39(3):407-13. PubMed ID: 15036400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE: a new pleiotropic antagonistic gene?
    Simm A; Bartling B; Silber RE
    Ann N Y Acad Sci; 2004 Jun; 1019():228-31. PubMed ID: 15247020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE in lung tumors.
    Franklin WA
    Am J Respir Crit Care Med; 2007 Jan; 175(2):106-7. PubMed ID: 17200506
    [No Abstract]   [Full Text] [Related]  

  • 10. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain.
    Ding Q; Keller JN
    Neurosci Lett; 2005 Jan; 373(1):67-72. PubMed ID: 15555779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous secretory receptor for advanced glycation end-products and cardiovascular disease in end-stage renal disease.
    Nishizawa Y; Koyama H
    J Ren Nutr; 2008 Jan; 18(1):76-82. PubMed ID: 18089449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products: sparking the development of diabetic vascular injury.
    Goldin A; Beckman JA; Schmidt AM; Creager MA
    Circulation; 2006 Aug; 114(6):597-605. PubMed ID: 16894049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGE-RAGE interactions: sticky sugar kills.
    Chee YC
    Singapore Med J; 2001 Apr; 42(4):145-7. PubMed ID: 11465312
    [No Abstract]   [Full Text] [Related]  

  • 14. RAGE axis: Animal models and novel insights into the vascular complications of diabetes.
    Naka Y; Bucciarelli LG; Wendt T; Lee LK; Rong LL; Ramasamy R; Yan SF; Schmidt AM
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1342-9. PubMed ID: 15155381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of advanced glycation end products and their receptors in development of diabetic neuropathy.
    Wada R; Yagihashi S
    Ann N Y Acad Sci; 2005 Jun; 1043():598-604. PubMed ID: 16037282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.
    Grillo MA; Colombatto S
    Amino Acids; 2008 Jun; 35(1):29-36. PubMed ID: 18008028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RAGE pathway: activation and perpetuation in the pathogenesis of diabetic neuropathy.
    Lukic IK; Humpert PM; Nawroth PP; Bierhaus A
    Ann N Y Acad Sci; 2008 Apr; 1126():76-80. PubMed ID: 18448798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
    Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
    J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.